BlueOcean
First Tokenized Medtech VC Fund
STO details
  • Token
    BOV
  • Platform
    Ethereum
  • Country
    United Kingdom
  • Whitelist/KYC
    KYC & Whitelist
  • Restricted areas
    China, Iran, North Korea

BlueOcean Ventures II has an experienced team with over 80 years of combined Start up and MedTech industry experience that knows how to identify the medtech startups that will deliver results – this team seamlessly increased BlueOcean Ventures II’s portfolio value by 48%until end 2017 (audited numbers).

BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field. For the first time, the BlueOcean STO gives investors the possibility of buying a tradable token (BOV Token) in the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments. 5 Existing portfolio companies, This STO will allow investing in more startups in order to reach a portfolio size of 8 to 12.

Our Special STO Investment Vehicle will become an investor into BlueOcean Ventures II making our token holders indirect shareholders into BlueOcean Ventures II.

During buyback events, revenue from BlueOcean Ventures II are transferred back to BlueOcean Ventures II’s investors, including our Special STO Investment Vehicle which in turn uses 100% of these proceeds to buy back your tokens at the token’s current market price or the token’s net asset value, whichever is higher. You are also permitted to sell your tokens at any time through our exchange partners.

BlueOcean Ventures II has an experienced team with over 80 years of combined Start up and MedTech industry experience that knows how to identify the medtech startups that will deliver results – this team seamlessly increasedBlueOcean Ventures II’s portfolio value by 48% until end 2017 (audited numbers).

Missing or incorrect data?
  • Emmanuel de Watteville
    General Partner and Co-Founder
  • Thomas Zehnder
    General Partner
  • Jean-Etienne Durand
    Head of Operations
  • Erik Roussel
    Fundraising
  • Roland Venesz
    Blockchain Architect
  • Antonio Gambardella
    Advisor
  • Viesturs Tamuzs
    Finance Advisor
  • Olivier Crochat
    Technology Advisor
  • Lug Giroud
    Marketing Advisor
  • Christophe Saam
    Swiss & European Patent Attorney
Missing or incorrect data?
  • 1
    2008

    Launch of BlueOcean Ventures I

  • 2
    2015

    Launch of the second fund, BlueOcean Ventures II

  • 3
    2016

    BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA

  • 4
    2017

    BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)

  • 5
    Q2 2018

    Set up of Special STO Investment Vehicle in Singapore

  • 6
    Q2 2018

    BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO

  • 7
    Q4 2018

    End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II

  • 8
    Q1 2019

    BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups

  • 9
    2020/2021

    BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company

Token info
  • Token
    BOV
  • Platform
    Ethereum
  • Type
    ERC20
Investment info
  • Accepting
    BTC, ETH, Fiat
  • Soft cap
    3,200,000 USD
  • Hard cap
    33,000,000 USD
Missing or incorrect data?
Token allocation model
Use of funds model